Literature DB >> 2545966

[A case of multiple sclerosing hemangiomas of the lung and a review of the literature in Japan].

K Maezato, S Hitomi, M Kuwabara.   

Abstract

A 39-year-old woman complained of an oppressive feeling in her chest and abnormal shadows were detected in the left lower lobe. On a preoperative diagnosis of primary or metastatic lung cancer, left lower lobectomy was performed. There were 3 nodular tumors in the left S6, S10 but no metastasis to regional lymph nodes was found. Histological examination confirmed "so-called" sclerosing hemangioma. She has remained well for 4 years after surgery. A review of the literatures on sclerosing hemangioma in Japan showed that 12 (5%) of 225 cases of sclerosing hemangiomas had multiple tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2545966

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  4 in total

1.  Genome profile in a extremely rare case of pulmonary sclerosing pneumocytoma presenting with diffusely-scattered nodules in the right lung.

Authors:  Xiangshan Fan; Ling Lin; Jianjun Wang; Yu Wang; Anning Feng; Ling Nie; Hongyan Wu; Fanqing Meng; Haodong Xu
Journal:  Cancer Biol Ther       Date:  2017-12-22       Impact factor: 4.742

2.  Bilateral multiple pulmonary sclerosing hemangioma.

Authors:  Jun Hanaoka; Masatsugu Ohuchi; Shuhei Inoue; Satoru Sawai; Noriaki Tezuka; Shozo Fujino
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-03

3.  Coexistence of Multiple Pulmonary Sclerosing Pneumocytoma and Scleroderma-Rheumatoid Arthritis Overlap Syndrome: A Case Report.

Authors:  Hülya Abalı; Fatma Tokgöz Akyıl; Seda Tural Önür; Neslihan Akanıl Fener; Aysun Ölçmen
Journal:  Turk Thorac J       Date:  2022-07

4.  Sixteen cases of sclerosing hemangioma of the lung including unusual presentations.

Authors:  Gou Young Kim; Jhingook Kim; Yong Soo Choi; Ho Joong Kim; Geunghwan Ahn; Joungho Han
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.